Cognitive function in patients prior to undergoing allogeneic hematopoietic stem cell transplantation

[1] Janelsins MC(2011)An update on cancer- and chemotherapy-related cognitive dysfunction: current status Semin Oncol 38 431-438

[2] Kohli S(2018)Prevalence of cognitive impairment and association with survival among older patients with hematologic cancers JAMA Oncol 4 686-693

[3] Mohile SG(2017)Cognitive impairment in breast cancer survivors treated with chemotherapy depends on control group type and cognitive domains assessed: a multilevel meta-analysis Neurosci Biobehav Rev 83 417-428

[4] Usuki K(2012)Cancer- and cancer treatment-associated cognitive change: an update on the state of the science J Clin Oncol 30 3675-3686

[5] Ahles TA(1983)Validation of a short orientation-memory-concentration test of cognitive impairment Am J Psychiatry 140 734-739

[6] Morrow GR(1983)The mini-mental state examination Arch Gen Psychiatry 40 812-699

[7] Hshieh TT(2005)The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment J Am Geriatr Soc 53 695-1278

[8] Jung WF(2008)Feasibility study of the Montreal Cognitive Assessment (MoCA) in patients with brain metastases Support Care Cancer 16 1273-1296

[9] Grande LJ(2011)Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401 J Clin Oncol 29 1290-303

[10] Chen J(2020)Screening for cognitive impairment in older adults with hematological malignancies using the Montreal Cognitive Assessment and neuropsychological testing J Geriatr Oncol 11 297-1235

[1] Janelsins MC(2011)An update on cancer- and chemotherapy-related cognitive dysfunction: current status Semin Oncol 38 431-438

[2] Kohli S(2018)Prevalence of cognitive impairment and association with survival among older patients with hematologic cancers JAMA Oncol 4 686-693

[3] Mohile SG(2017)Cognitive impairment in breast cancer survivors treated with chemotherapy depends on control group type and cognitive domains assessed: a multilevel meta-analysis Neurosci Biobehav Rev 83 417-428

[4] Usuki K(2012)Cancer- and cancer treatment-associated cognitive change: an update on the state of the science J Clin Oncol 30 3675-3686

[5] Ahles TA(1983)Validation of a short orientation-memory-concentration test of cognitive impairment Am J Psychiatry 140 734-739

[6] Morrow GR(1983)The mini-mental state examination Arch Gen Psychiatry 40 812-699

[7] Hshieh TT(2005)The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment J Am Geriatr Soc 53 695-1278

[8] Jung WF(2008)Feasibility study of the Montreal Cognitive Assessment (MoCA) in patients with brain metastases Support Care Cancer 16 1273-1296

[9] Grande LJ(2011)Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401 J Clin Oncol 29 1290-303

[10] Chen J(2020)Screening for cognitive impairment in older adults with hematological malignancies using the Montreal Cognitive Assessment and neuropsychological testing J Geriatr Oncol 11 297-1235